John Edwards is founder and CEO of Drusolv Therapeutics. Mr. Edwards is a seasoned entrepreneur with 25 years in medical product development and commercialization, including 12 years focused on AMD. Drusolv is his fifth startup venture. Of the previous four, one was acquired, one went public, one failed, and one – MacuLogix – is an ongoing company successfully commercializing a diagnostic for early detection of AMD. He is now devoted full time to Drusolv. Mr. Edwards has BS and MS degrees in physics from MIT and an MBA from University of Chicago.